A prospective, randomized, double-blind, placebo-controlled study to evaluate the safety of a bivalent vaccine of new 6:2 influenza virus reassortants in healthy adults
Latest Information Update: 26 Jul 2007
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors MedImmune
- 09 Jan 2007 Status change
- 12 Nov 2006 New trial record.